Identifíquese
¿Aún no es suscriptor de la revista?
Comprar el acceso al artículo
Comprando el artículo el pdf del mismo podrá ser descargado
Teléfono para incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Bibliografía
[1]
M. Pimentel, R.J. Saad, M.D. Long, S.S.C. Rao.
ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.
Am J Gastroenterol., (2020), 115 pp. 165-178
[2]
G. Losurdo, G. Leandro, E. Ierardi, F. Perri, M. Barone, M. Principi, et al.
Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis.
J Neurogastroenterol Motil., (2020), 26 pp. 16-28
[3]
D. Bushyhead, E.M.M. Quigley.
Small Intestinal Bacterial Overgrowth-Pathophysiology and Its Implications for Definition and Management.
Gastroenterology., (2022), 163 pp. 593-607
[4]
A. Shah, N.J. Talley, M. Jones, B.J. Kendall, N. Koloski, M.M. Walker, et al.
Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
Am J Gastroenterol., (2020), 115 pp. 190-201
[5]
A. Rezaie, M. Buresi, A. Lembo, H. Lin, R. McCallum, S. Rao, et al.
Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus.
Am J Gastroenterol., (2017), 112 pp. 775-784
[6]
E.M.M. Quigley, J.A. Murray, M. Pimentel.
AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review.
Gastroenterology., (2020), 159 pp. 1526-1532
[7]
H.F. Hammer, M.R. Fox, J. Keller, S. Salvatore, G. Basilisco, J. Hammer, et al.
European H2-CH4-breath test group. European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus.
United European Gastroenterol J., (2022), 10 pp. 15-40
[8]
G.B. Saffouri, R.R. Shields-Cutler, J. Chen, Y. Yang, H.R. Lekatz, V.L. Hale, et al.
Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders.
Nat Commun., (2019), 10 pp. 2012
[9]
V. Martín Domínguez, C. Malagelada, C. Santander.
Small intestinal bacterial overgrowth. A position paper of ASENEM-SEPD.
Rev Esp Enferm Dig., (2023), 115 pp. 679-681
[10]
L. Gatta, C. Scarpignato.
Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth.
Aliment Pharmacol Ther., (2017), 45 pp. 604-616
[11]
J. Wang, L. Zhang, X. Hou.
Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis.
Expert Rev Gastroenterol Hepatol., (2021), 15 pp. 1385-1399
